共 50 条
Acute Kidney Injury in Critically Ill Patients with Cancer
被引:26
|作者:
Gupta, Shruti
[1
]
Gudsoorkar, Prakash
[2
]
Jhaveri, Kenar D.
[3
]
机构:
[1] Brigham & Womens Hosp, Div Renal Med, Boston, MA USA
[2] Univ Cincinnati, Res & Educ Program, Div Nephrol & Kidney Clin Advancement, Cincinnati, OH USA
[3] Donaldand Barbara Zucker Sch Med, Div Kidney Dis & Hypertens, Great Neck, NY USA
来源:
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
|
2022年
/
17卷
/
09期
关键词:
critical care nephrology and acute kidney injury series;
onconephrology;
cancer;
AKI;
drug nephrotoxicity;
acute kidney injury;
ACUTE-RENAL-FAILURE;
INDUCED THROMBOTIC MICROANGIOPATHY;
TUMOR LYSIS SYNDROME;
HEMOLYTIC-UREMIC SYNDROME;
MYELOMA CAST NEPHROPATHY;
NON-HODGKINS-LYMPHOMA;
RISK-FACTORS;
URIC-ACID;
PLASMA-EXCHANGE;
CISPLATIN NEPHROTOXICITY;
D O I:
10.2215/CJN.15681221
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Critically ill cancer patients have a higher incidence of acute kidney injury treated with renal replacement therapy than critically ill patients without cancer. Acute kidney injury may occur as a direct or indirect consequence of the cancer itself, its treatment, or associated complications. Several recent studies have shown that the presence of an underlying cancer alone can no longer be considered a contraindication to initiate renal replacement therapy or other advanced life-supportive measures in critically ill patients. However, these relatively good results should not be used to justify unrealistic therapeutic perseverance or to withhold palliative care in cancer patients who are in a desperate situation. Similar to that for any other critically ill patient, the decision to initiate advanced life-supportive therapy as well as its duration should be in proportion with the patient's expected long-term prognosis and quality of life.
引用
收藏
页码:1385 / 1398
页数:14
相关论文